Trial · NCT01037218

Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Udenafil 50 mg	147
Overall Study	STARTED	Udenafil 100 mg	149
Overall Study	STARTED	Udenafil 150mg	155
Overall Study	STARTED	Placebo	150
Overall Study	Safety Population	Udenafil 50 mg	147
Overall Study	Safety Population	Udenafil 100 mg	148
Overall Study	Safety Population	Udenafil 150mg	154
Overall Study	Safety Population	Placebo	150
Overall Study	mITT Population	Udenafil 50 mg	141
Overall Study	mITT Population	Udenafil 100 mg	140
Overall Study	mITT Population	Udenafil 150mg	147
Overall Study	mITT Population	Placebo	141
Overall Study	COMPLETED	Udenafil 50 mg	131
Overall Study	COMPLETED	Udenafil 100 mg	128
Overall Study	COMPLETED	Udenafil 150mg	134
Overall Study	COMPLETED	Placebo	134
Overall Study	NOT COMPLETED	Udenafil 50 mg	16
Overall Study	NOT COMPLETED	Udenafil 100 mg	21
Overall Study	NOT COMPLETED	Udenafil 150mg	21
Overall Study	NOT COMPLETED	Placebo	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01037218/flow